Cargando…

Cost-effectiveness of diagnostic tests during follow-up in lung cancer patients: an evidence-based study

BACKGROUND: Many patients with non-metastatic non-small cell lung cancer (NSCLC) are cured by surgery but part of them develop recurrence. Strategies are needed to identify these relapses. Currently, there is no consensus on the follow-up schedule after curative resection for patients with NSCLC. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Cano, Fernando, Calvo, Virginia, Garitaonaindía, Yago, Campo-Cañaveral de la Cruz, José Luis, Blanco, Mariola, Torrente, María, Provencio, Mariano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989820/
https://www.ncbi.nlm.nih.gov/pubmed/36895936
http://dx.doi.org/10.21037/tlcr-22-540
_version_ 1784901834693935104
author Rodríguez-Cano, Fernando
Calvo, Virginia
Garitaonaindía, Yago
Campo-Cañaveral de la Cruz, José Luis
Blanco, Mariola
Torrente, María
Provencio, Mariano
author_facet Rodríguez-Cano, Fernando
Calvo, Virginia
Garitaonaindía, Yago
Campo-Cañaveral de la Cruz, José Luis
Blanco, Mariola
Torrente, María
Provencio, Mariano
author_sort Rodríguez-Cano, Fernando
collection PubMed
description BACKGROUND: Many patients with non-metastatic non-small cell lung cancer (NSCLC) are cured by surgery but part of them develop recurrence. Strategies are needed to identify these relapses. Currently, there is no consensus on the follow-up schedule after curative resection for patients with NSCLC. The objective of this study is to analyze the diagnostic capacity of the tests performed during follow-up after surgery. METHODS: We retrospectively reviewed 392 patients with stage I–IIIA NSCLC who underwent surgery. Data were collected from patients diagnosed between January 1st, 2010 and December 31st, 2020. Demographic and clinical data were analyzed, as well as the tests performed during their follow-up. We identified as relevant in the diagnosis of relapses those tests that prompted further investigation and change of treatment. RESULTS: The number of tests matches those included in clinical practice guidelines. A total of 2,049 clinical follow-up consultations were performed, of which 2,004 were scheduled (0.59% informative). A total of 1,796 blood tests were performed, of which 1,756 were scheduled (0.17% informative). A total of 1,940 chest computer tomography (CT) scans were performed, of which 1,905 were scheduled and 128 were informative (6.7%). A total of 144 positron emission tomography (PET)-CT scans were performed, 132 of which were scheduled, of which 64 (48%) were informative. In all cases, the tests performed by unscheduled request exceeded the informative result of the scheduled ones several fold. CONCLUSIONS: Most of the scheduled follow-up consultations were not relevant for the patients’ management, and only body CT scan exceeded the threshold of 5% profitability, without reaching 10% even in stage IIIA. The profitability of the tests increased when performed in unscheduled visits. New follow-up strategies based on scientific evidence must be defined and follow-up schemes should be tailored focused on agile attention of the unscheduled demand.
format Online
Article
Text
id pubmed-9989820
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-99898202023-03-08 Cost-effectiveness of diagnostic tests during follow-up in lung cancer patients: an evidence-based study Rodríguez-Cano, Fernando Calvo, Virginia Garitaonaindía, Yago Campo-Cañaveral de la Cruz, José Luis Blanco, Mariola Torrente, María Provencio, Mariano Transl Lung Cancer Res Original Article BACKGROUND: Many patients with non-metastatic non-small cell lung cancer (NSCLC) are cured by surgery but part of them develop recurrence. Strategies are needed to identify these relapses. Currently, there is no consensus on the follow-up schedule after curative resection for patients with NSCLC. The objective of this study is to analyze the diagnostic capacity of the tests performed during follow-up after surgery. METHODS: We retrospectively reviewed 392 patients with stage I–IIIA NSCLC who underwent surgery. Data were collected from patients diagnosed between January 1st, 2010 and December 31st, 2020. Demographic and clinical data were analyzed, as well as the tests performed during their follow-up. We identified as relevant in the diagnosis of relapses those tests that prompted further investigation and change of treatment. RESULTS: The number of tests matches those included in clinical practice guidelines. A total of 2,049 clinical follow-up consultations were performed, of which 2,004 were scheduled (0.59% informative). A total of 1,796 blood tests were performed, of which 1,756 were scheduled (0.17% informative). A total of 1,940 chest computer tomography (CT) scans were performed, of which 1,905 were scheduled and 128 were informative (6.7%). A total of 144 positron emission tomography (PET)-CT scans were performed, 132 of which were scheduled, of which 64 (48%) were informative. In all cases, the tests performed by unscheduled request exceeded the informative result of the scheduled ones several fold. CONCLUSIONS: Most of the scheduled follow-up consultations were not relevant for the patients’ management, and only body CT scan exceeded the threshold of 5% profitability, without reaching 10% even in stage IIIA. The profitability of the tests increased when performed in unscheduled visits. New follow-up strategies based on scientific evidence must be defined and follow-up schemes should be tailored focused on agile attention of the unscheduled demand. AME Publishing Company 2023-02-05 2023-02-28 /pmc/articles/PMC9989820/ /pubmed/36895936 http://dx.doi.org/10.21037/tlcr-22-540 Text en 2023 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Rodríguez-Cano, Fernando
Calvo, Virginia
Garitaonaindía, Yago
Campo-Cañaveral de la Cruz, José Luis
Blanco, Mariola
Torrente, María
Provencio, Mariano
Cost-effectiveness of diagnostic tests during follow-up in lung cancer patients: an evidence-based study
title Cost-effectiveness of diagnostic tests during follow-up in lung cancer patients: an evidence-based study
title_full Cost-effectiveness of diagnostic tests during follow-up in lung cancer patients: an evidence-based study
title_fullStr Cost-effectiveness of diagnostic tests during follow-up in lung cancer patients: an evidence-based study
title_full_unstemmed Cost-effectiveness of diagnostic tests during follow-up in lung cancer patients: an evidence-based study
title_short Cost-effectiveness of diagnostic tests during follow-up in lung cancer patients: an evidence-based study
title_sort cost-effectiveness of diagnostic tests during follow-up in lung cancer patients: an evidence-based study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989820/
https://www.ncbi.nlm.nih.gov/pubmed/36895936
http://dx.doi.org/10.21037/tlcr-22-540
work_keys_str_mv AT rodriguezcanofernando costeffectivenessofdiagnostictestsduringfollowupinlungcancerpatientsanevidencebasedstudy
AT calvovirginia costeffectivenessofdiagnostictestsduringfollowupinlungcancerpatientsanevidencebasedstudy
AT garitaonaindiayago costeffectivenessofdiagnostictestsduringfollowupinlungcancerpatientsanevidencebasedstudy
AT campocanaveraldelacruzjoseluis costeffectivenessofdiagnostictestsduringfollowupinlungcancerpatientsanevidencebasedstudy
AT blancomariola costeffectivenessofdiagnostictestsduringfollowupinlungcancerpatientsanevidencebasedstudy
AT torrentemaria costeffectivenessofdiagnostictestsduringfollowupinlungcancerpatientsanevidencebasedstudy
AT provenciomariano costeffectivenessofdiagnostictestsduringfollowupinlungcancerpatientsanevidencebasedstudy